The ValiMed Medication Validation System and related information are now available at http://publicrelationsnewsroom.com/_wsn/page19.html for media and professional access. ValiMed, distributed by Baxa Corporation,
uses enhanced photoemission spectroscopy to quickly validate high-risk medication admixtures, as well as returned narcotics to provide an increased level of patient safety. ValiMed
compares a medication'ss spectroscopic signature to the Medication Signature Library and returns an easy-to-understand validated or not validated result, requiring no user
interpretation.
The expanded ValiMed System features patented technology that validates in seconds compounded doses of high-risk medications prior to dispensing. Verification of compounding accuracy is a
requirement under USP 27-NF 22 Chapter 797, which regulates the compounding of sterile products. The ValiMed System can play a key role in demonstrating the safety of compounded sterile
products (CSPs) under these requirements.
This expanded ValiMed System incorporates reports supporting compliance with USP 797 requirements. It also features a modified disposable, requiring a reduced (0.25 mL) sample volume for
testing. This next-generation ValiMed System addresses customer requests, notes Baxa Corporation Product Manager Mark Thrasher. The addition of a quality assurance feature meets the
regulatory requirements, while the smaller sample requirement more easily accommodates current pharmacy work flows.
Baxa, a long-time proponent of hospital pharmacy safety initiatives, recently launched its state-of-the-art STAR (Skills Training, Academics and Resources) Center for pharmacy and
cleanroom skills training. Products such as the ValiMed Medication Validation System can be demonstrated and evaluated there, as part of a technology overview for best practices. Baxa
designed and built the STAR Center as a fully USP 797-compliant pharmacy cleanroom to provide professional education on pharmacy practice, cleanroom principles and compliance to
regulatory requirements. The STAR Center, the only dedicated facility of its kind in the world for hands-on cleanroom experience and training in environmental monitoring and aseptic
technique, provides a unique opportunity for industry professionals to learn best practice from subject-matter expert trainers. More information is available at http://www.baxa.com/starcenter
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient
preparation, handling, packaging and administration of fluid medications. Key products include Rapid-Fill's8482; Automated Syringe Fillers, Exacta-Med® Oral Dispensers, MicroFuse® Syringe
Infusers, Repeater's8482; Pharmacy Pumps, and Exacta-Mix's8482; and MicroMacro's8482; Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately
held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg and The
Netherlands; and distribution partners worldwide. Further information is available at http://www.baxa.com
About CDEX, Inc.
CDEX Inc. is a technology development company with a current focus on developing and marketing products using chemical detection and validation technologies. At present, CDEX is devoting
its resources to two distinct areas: (I) identification of substances of concern (e.g., explosives and illegal drugs for homeland security); and (II) validation of substances for
anti-counterfeiting, brand protection and quality assurance (e.g., validation of prescription medication and detection of counterfeit or sub-par products for brand protection). ValiMed is
a CDEX solution for the healthcare market. Corporate headquarters and research and development facilities for CDEX are located in Tucson, Arizona. For more information, visit http://www.cdex-inc.com and http://www.valimed.com or contact CDEX, Inc. at 520.745.5172,
Contacts:
Baxa Corporation
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
http://www.baxa.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations
303.984.9801, 303.669.3558
http://www.absolutelypr.com
CDEX Inc.
Malcolm Philips or Stuart Poteet
520.745.5172